This special emphasis panel reviews small business applications related to the function, physiology and pathophysiology of the digestive system, including digestive diseases and inflammatory conditions, mucosal immunology and host-pathogen interactions in the context of digestive disease, the microbiome, GI motility, brain-gut interactions, nutrition including nutrient adsorption and metabolism, the exocrine pancreas and pancreatic disease, liver and hepatobiliary physiology and pathophysiology.

Review Dates

Topics


  • Development and evaluation of new techniques for investigating, diagnosing and treating disorders of the gastrointestinal tract, liver and pancreas.
  • Development of new techniques for the evaluation and treatment of Gastroesophageal Reflex Disease (GERD).
  • Application of new technologies and methodologies to the diagnosis and treatment of Inflammatory Bowel disease (IBD) including Crohn’s and ulcerative colitis, MASH, MAFLD, ALD and liver fibrosis.
  • Novel approaches to regeneration and tissue engineering of the gastrointestinal tract, liver and pancreas. 
  • Novel approaches to liver transplant and tissue preservation.
  • Development of pre- and probiotic based therapies for the treatment of gastrointestinal and liver disease.
  • Clinical assessment and treatment strategies for gastrointestinal diseases, for example fecal incontinence, colon polyps, short bowel syndrome.
  • Manipulation of microbiome and microbiome-based treatment strategies for digestive diseases.
  • The development of In vitro, ex-vivo model systems for studying GI and liver diseases.

 

Last updated: 02/20/2026 04:32